Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research
Agreement brings CAP and NYS CLEP-approved genotyping test to a multi-site Alzheimer’s clinical research network
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.